Chest CT Biomarkers as Prognostic Predictors in SSc-ILD
This study is investigating whether special details found in CT scans of the lungs can help predict how lung disease (called ILD) might progress in people with Systemic Sclerosis (SSc). Many people with SSc develop ILD, where the lungs become scarred and stiff. For some, this condition remains stable, but for others, it gets worse. Doctors need better ways to tell who is at higher risk of their lung condition worsening so they can get the right treatment early. This study uses advanced computer analysis of CT scans from the past to look for specific patterns in the airways, blood vessels, and scar tissue. The goal is to see if these patterns can predict changes in lung function and survival.
At a glance
What is this study about?
If you have Systemic Sclerosis (SSc), you might already know that many people with this condition can also develop a lung problem called Interstitial Lung Disease (ILD). This is when the lungs become scarred and stiff, making it harder to breathe. For some people, this scarring might stay the same for a long time, but for others, it can get worse over time.
Doctors are always looking for better ways to understand who might be at a higher risk of their ILD worsening, and who might be at a lower risk. This is really important because it helps them decide who needs treatment right away to stop the scarring from getting worse, and who might not need immediate treatment. This study is trying to find these early warning signs by looking very closely at special CT scans of the lungs.
The research team is using advanced computer programs to analyse these CT scans. They are looking for tiny details in the airways (the tubes that carry air in and out of your lungs), the blood vessels in your lungs, and the overall amount of scarring. They hope that by identifying specific patterns in these scans, they will be able to predict if someone's lung condition is likely to get worse, how it might affect their lung function over time, and even their long-term health. The results could help doctors give patients more personalised care in the future.
Key takeaways
- This study aims to discover early indicators of lung disease progression in SSc patients.
- It uses advanced computer analysis of past HRCT lung scans.
- The goal is to help doctors predict which patients might need earlier treatment.
- No new tests or active participation are required from patients.
- The study could lead to more personalised care for SSc-ILD in the future.
- Your data will be kept private and anonymised.
Who may be eligible?
To be considered for this study, you would need to have been diagnosed with Systemic Sclerosis (SSc) and be at least 18 years old. Importantly, the study needs to be able to access a specific type of lung scan, called an HRCT, that you would have had between January 1, 1990, and December 31, 2019.
On the other hand, you would not be able to be part of this study if you haven't been diagnosed with SSc, are under 18 years old, or if your HRCT scan data from the specified time period isn't available.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I have been diagnosed with Systemic Sclerosis (SSc).
- I am 18 years old or older.
- I had an HRCT lung scan between January 1, 1990, and December 31, 2019.
- My HRCT scan data is available for research.
What does participation involve?
This is a 'retrospective observational study,' which means it looks back at information that has already been collected. If you were to take part, you wouldn't need to do anything new. You wouldn't have any extra hospital visits, assessments, or take any medication specifically for this study. The researchers would collect and analyse information from your past medical records, focusing on your existing HRCT lung scans. Therefore, there's no active participation required from you once you give your consent for your data to be used.
Potential risks and benefits
Locations (7)
- Bichat-Claude Bernard hospitalVerified postcodeParis, France
- Hanover Medical SchoolVerified postcodeHanover, Germany
- Marche Polytechnic UniversityVerified postcodeAncona, Italy
- Sassari UniversityVerified postcodeSassari, Italy
- Siena University HospitalVerified postcodeSiena, Italy
- Leeds Hospital/University of LeedsVerified postcodeLeeds, United Kingdom
- Royal Brompton HospitalVerified postcodeLondon, United Kingdom
Common questions
What is Systemic Sclerosis (SSc)?
SSc is a rare, long-term condition that causes hardening and tightening of the skin and connective tissues, which can affect internal organs like the lungs.
What is ILD?
ILD stands for Interstitial Lung Disease. It's a condition where the tissues in and around your air sacs in the lungs become scarred, making them stiff and less able to take in oxygen.
What is an HRCT scan?
An HRCT (High-Resolution Computed Tomography) scan is a detailed type of X-ray that shows clear pictures of your lungs, helping doctors see tiny changes.
Will this study require new tests or appointments?
No, this study only uses information from past medical records and HRCT scans you've already had. You won't need any new tests or appointments.
How will my personal information be protected?
All your personal information will be kept private and handled securely. The researchers will use anonymised data so your identity is protected.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.